Stifel Europe

A pan-European investment bank offering comprehensive international research.

Expanding Stifel Investment Banking Across European Borders

We firmly believe that clients value authentic advice and enduring relationships. Our goal is to offer these across a comprehensive range of industry coverage groups.

Stifel is a leading full-service investment bank for European growth companies and their investors. Clients benefit from our unwavering commitment to their long-term success, leveraging our unmatched insights into strategically important sectors. Our strong relationships with investors, ranging from private equity and venture capital to institutional investors across Stifel’s global footprint, including the U.S., Europe, Canada, Israel, Latin America, and Asia, further enhance our clients’ ability to achieve their objectives.

Learn more about our Global Investment Banking Practice

Introducing Stifel IRIS, a library of innovative thought leadership content, sharing how our global team thinks about today’s markets.

Learn More

Our Services

Our Sector Expertise

Consumer

The consumer sector is experiencing a significant transformation across various segments, including food, electronics, entertainment, and travel. This shift is driven by the engagement of digital natives with brands, products, and the environment. The European Consumer Investment Banking team offers a comprehensive suite of advisory and capital markets services to clients across all major sector sub-verticals, such as active lifestyle, apparel & footwear, beauty, DTC & E-commerce, food & beverage, home, and specialty retail.

Our team boasts a successful track record in equity capital-raisings, IPOs, sell-downs, and both sell-side and buy-side M&A transactions, including numerous cross-border assignments. Our success is built on deep global industry knowledge, unrivaled market access, and insightful perspectives, providing clients with a unique offering that delivers the most relevant and commercially focused advice. Given the global nature of the Consumer & Retail sector, we collaborate closely with Stifel’s U.S. and other international offices to ensure our clients' needs are met with a global perspective .

Business Services

Stifel’s European Business Services team advises on a diverse range of transactions including private buy-side and sell-side M&A, public takeovers and defence, strategic advisory and investor positioning assignments, in addition to IPO's, rights issues, equity private placements, and investment and sub-investment grade financings.

We work closely with public and private clients across Continental Europe, North America, the Middle East, and Asia on transactions with a particular focus on Testing, Inspection, Certification & Compliance; Engineering & Infrastructure Services; Environmental/ESG Services; Speciality Rental; Speciality Consulting; Distribution; Industrial & Technical Services; Facility Services; B2C; BPO; and Human Capital Services.

Capital Solutions

Stifel's London-based Capital Solutions Group (CSG) offers borrowers a full range of public and private capital markets solutions designed to span the full corporate lifecycle including complex and distressed situations. We work closely with clients across a wide range of industries and jurisdictions to communicate their credit stories to a targeted investor audience and create tailored debt financing structures. CSG leverages Stifel’s global coverage of more than 8,000 accounts, from large institutions to private wealth, to find the right pockets of capital. CSG is also able to advise on restructuring and liability management processes with a focus on early identification of credit related issues and a proactive approach in resolving any commercial, financial, or structural issues.

Diversified Industries

The Diversified Industries Investment Banking Group provides advisory and capital-raising services to companies and financial sponsors. The Group offers its clients advice and execution on mergers & acquisitions, access to public and private equity and debt capital, and other financial advisory services, including fairness opinions, in numerous industries ranging from aerospace and clean technology to engineering and logistics.

Equity Capital Markets

Energy & Natural Resources

The European Energy & Natural Resources Investment Banking team offers capital markets and advisory services to clients in the oil & gas, mining, and clean energy sectors. As the market leader in London for oil & gas equity capital-raisings, IPOs, and sell-downs, our team's success is built on deep industry and regulatory knowledge, coupled with unrivaled market access and insight.

We provide clients with a unique offering that delivers the most relevant and commercially focused advice. Our full-service capabilities include equity capital markets, M&A advisory, regulatory advisory (Nomad, Sponsor, Takeover Code), debt capital markets, and acquisition and divestment services for oil & gas operators.

Financial Sponsors

Financial Institutions & Financial Technology

The UK Financial Institutions & Fintech Investment Banking Team, operating under KBW, provides capital markets and advisory services to clients across the financial services industry. We focus on the insurance, banking, specialty finance, asset management, and financial technology subsectors. As a market leader in Europe for M&A advisory, capital-raisings (equity and debt), and IPOs, our team's success is built on deep industry and regulatory knowledge, coupled with unrivaled market access and insight.

By combining these elements into a single team, we offer clients a unique service capable of delivering the most relevant and commercially focused advice.

Healthcare

Stifel’s European Healthcare team provides capital markets and advisory services on a pan-European and global basis across the full spectrum of healthcare companies, including Biotech, MedTech, diagnostics, animal health, OTC and specialty pharma, as well as outsourced pharma services and healthcare services. Our full-service product offering includes M&A (both company and asset-based), equity capital-raising (including IPOs and follow-on offerings), corporate broking services for listed companies, and capital solutions.

We have expertise in helping European biotechnology companies access the U.S. capital markets and maintain a leading global franchise in branded healthcare products such as animal health and OTC/consumer health. Our team's success is built on deep industry and scientific knowledge, exceptional access to investors, and global connectivity in our core segments. This enables us to offer a comprehensive and integrated approach to addressing clients’ needs effectively.

Additionally, we operate in close coordination with our U.S. banking partners, providing a highly differentiated proposition for UK and European companies raising capital in the U.S.

Investment Funds & Real Estate

Stifel Europe’s Real Estate Investment Funds Group provides specialist financing and advisory services. We pride ourselves on offering independent and non-conflicted advice to our corporate clients, who benefit from our comprehensive range of investment banking services. Our success is underpinned by unrivaled sector expertise and insights.

Our market-leading Real Estate franchise advises clients across various sub-sectors, including healthcare, student accommodation, long-income, office, industrial, prime Central London, strategic land, and residential. As a specialist and leading corporate finance adviser, we serve more than 20 retained investment funds clients with an average market cap of over £500 million, devising and implementing long-term equity issuance growth strategies and secondary market promotional activities.

Infrastructure

Stifel’s Infrastructure Investment Banking team specializes in M&A, debt, and strategic advisory services for infrastructure and private equity funds, sovereign wealth funds, pension funds, and insurance companies across the infrastructure sector. We offer clients tailored and innovative capital solutions, leveraging deep expertise across various infrastructure sectors, including renewable and conventional power (utility-scale and distribution level), energy transition, regulated utilities, transportation, logistics, telecoms, waste, recycling, district heating, and storage.

Legal Services

Stifel’s Legal Services Group focuses exclusively on law firms, litigation finance, and other legal services assets. Our team has advised on numerous transactions across the capital structure (debt and equity, private and public), spanning the investment banking product set (public equity, private equity, M&A, structured debt), and across the globe (U.S., UK, and Continental Europe).

We advised Gerchen Keller on its disposal to Burford, the largest M&A deal in the sector to date, led the IPO of DWF onto the Main List of the London Stock Exchange, and successfully executed structured private credit transactions for litigation finance platforms, giving us an unrivaled understanding of private cost of capital.

Technology

Offering a world-class combination of deep sector knowledge, strong industry relationships, and broad product expertise, our team provides clients with strategic advisory and capital-raising services designed to support growth companies and their investors during all stages of their development.

With more than 100 professionals working as an integrated team across North America and Europe, Stifel is one of the leading providers of capital-raising services to technology companies and technology-focused institutional investors.

UK Corporate Broking

Stifel is a leading UK corporate broker with retained relationships across multiple sectors with companies listed on the Main Market and AIM. We offer a range of services to our corporate clients, providing them with support in the equity capital markets, as well as insightful advice on M&A, defence and debt capital markets.

Stifel is increasingly broadening its sector footprint, with significant momentum and recent clients wins in the Healthcare, Technology and Financials sectors complementing ongoing mid-market leadership in Real Estate, Energy and Resources, and Investment Funds.

Notable Transactions

Undisclosed

M&A

Mergers & Acquisitions

Mergers & Acqusitions

Undisclosed

Software & Fintech

Mar 2023

€ 515 000 000

Follow-on Offering

Healthcare

2023

€ 75 000 000

M&A | Buy Side

Mergers & Acquisitions

Aerospace, Defense & Government Services

May 2024

Undisclosed

M&A

Mergers & Acquisitions

Healthcare

2024

$ 379 000 000

Follow-on Offering

Healthcare

2024

€ 127 000 000

Follow-on Offering

Healthcare

2024

C$ 145 000 000

ECM | Follow-on Offering

Follow-on Offering

Healthcare

2024

Undisclosed

M&A

Mergers & Acquisitions

NextGen Consumer

Jun 2022

Undisclosed

M&A

Mergers & Acquisitions

Healthcare

Jun 2022

Undisclosed

Private Placement

Software & Fintech

Jul 2022

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Software & Fintech

Jul 2022

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Aug 2022

Undisclosed

M&A

Mergers & Acquisitions

NextGen Consumer

Sep 2022

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Sep 2022

€ 102 900 000

Follow-on Offering

Healthcare

Sep 2022

€ 100 000 000

M&A

Mergers & Acquisitions

Healthcare

Oct 2022

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Oct 2022

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Oct 2022

€ 110 000 000

Private Placement

Software & Fintech

Nov 2022

Undisclosed

Private Placement

Software & Fintech

Dec 2023

Undisclosed

Private Placement

Healthcare

Jan 2023

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Jan 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jul 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jul 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jul 2023

€ 170 000 000

M&A

Evolucare - Mergers & Acquisitions

Software & Fintech

Jul 2023

Undisclosed

M&A

Ekoscan Integrity - Mergers & Acquisition

Climate & Industrial Tech

Aug 2023

€ 150 000 000

Debt Advisory

Healthcare

Aug 2023

Undisclosed

M&A Sell Side

Mergers & Acquisitions

Business & Tech-enabled Services

Sep 2023

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Sep 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Sep 2023

€ 875 000 000

M&A, Debt Financing & Take Private

Mergers & Acquisitions

Healthcare

Oct 2023

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Oct 2023

$ 236 000 000

Initial Public Offering

Healthcare

Oct 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Nov 2023

Undisclosed

M&A

Mergers & Acquisitions

Healthcare

Nov 2023

C$ 450 000 000

Follow-on Offering

Climate & Industrial Tech

Nov 2023

€ 92 000 000

Debt

Senior Secured Term Loan

Healthcare

Dec 2023

$ 275 000 000

Convertible Bond

Follow-on Offering

Climate & Industrial Tech

Dec 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jan 2024

SEK 1 090 000 000

Follow-on Offering

Healthcare

Jan 2024

€ 70 000 000

Follow-on Offering

Climate & Industrial Tech

Feb 2024

Undisclosed

M&A

Mergers & Acquisitions

Business & Tech-enabled Services

Mar 2024

€ 52 000 000

Follow-on Offering

Climate & Industrial Tech

Mar 2024

€ 108 000 000

Senior Secured Term Loan

NextGen Consumer

Apr 2024

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Apr 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Healthcare

May 2024

SEK 715 000 000

ECM | Initial Public Offering

Initial Public Offering

Healthcare

Jun 2024

Undisclosed

M&A | Buy Side

Mergers & Acquisitions

Business & Tech-enabled Services

Jul 2024

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jul 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jul 2024

Undisclosed

Private Placement

Climate & Industrial Tech

Sep 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Business & Tech-enabled Services

Sep 2024

Undisclosed

M&A | Buy Side

Mergers & Acquisitions

Business & Tech-enabled Services

Sep 2024

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Sep 2024

€ 61 180 000

ECM||Follow-on Offering

Follow-on Offering

Healthcare

Sep 2024

SEK 300 000 000

ECM | Follow-on Offering

Follow-on Offering

Healthcare

Sep 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Software & Fintech

Oct 2024

SEK 462 000 000

Private Placement

Healthcare

Oct 2023

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Climate & Industrial Tech

Oct 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Software & Fintech

Oct 2024

€ 70 000 000

ECM | Follow-on Offering

Follow-on Offering

Feb 2024

SEK 972 000 000

ECM | Follow-on Offering

Follow-on Offering

Healthcare

Jan 2024

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Oct 2024

SEK 210 000 000

Follow-on Offering

Healthcare

Jan 2023

€ 141 000 000

Rights Issue

Follow-on Offering

Climate & Industrial Tech

Jul 2023

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Software & Fintech

Nov 2024

Undisclosed

M&A

Mergers & Acquisitions

NextGen Consumer

Feb 2023

C$ 126 000 000

Follow-on Offering

Climate & Industrial Tech

Jun 2023

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Business & Tech-enabled Services

Nov 2024

€ 20 029 968

Follow-on Offering

Climate & Industrial Tech

Feb 2023

€ 130 000 000

Follow-on Offering

Healthcare

Feb 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Apr 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Apr 2023

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Jun 2023

Undisclosed

M&A

Mergers & Acquisitions

Healthcare

May 2023

$ 250 000 000

M&A

Mergers & Acquisitions

Software & Fintech

May 2023

Undisclosed

M&A

Mergers & Acquisitions

Climate & Industrial Tech

Jun 2023

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Business & Tech-enabled Services

Nov 2024

Undisclosed

M&A||Sell Side

Mergers & Acquisitions

Climate & Industrial Tech

Dec 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Climate & Industrial Tech

Dec 2024

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Climate & Industrial Tech

Dec 2024

Undisclosed

M&A

Mergers & Acquisitions

Software & Fintech

Dec 2024

£ 23 000 000

Private Placement

Business & Tech-enabled Services

Jan 2025

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Software & Fintech

Feb 2025

Undisclosed

M&A | Sell Side

Mergers & Acquisitions

Climate & Industrial Tech

Feb 2025

Advisor to Seller

Mergers & Acquisitions

Engineering & Construction, and Infrastructure

Mar 2025

Advisor to Buyer

Mergers & Acquisitions

Healthcare

Feb 2025

A$ 80,000,000

Joint Lead Arranger & Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2025

$ 1,075,000,000

Joint Lead Arranger

Senior Secured Credit Facilities

Packaging, Diversified Industries

Dec 2024

Advisor to Seller

Mergers & Acquisitions

Consumer

Sep 2024

$ 46,300,000

Capital Markets Advisor, Bookrunner & Sole Placing Agent

Reverse Takeover & Equity Placing

Energy & Natural Resources

Sep 2024

Advisor to Seller

Mergers & Acquisitions

Technology

Oct 2024

£ 380,000,000

Advisor to Seller

Mergers & Acquisitions

Healthcare

Jan 2024

Sole Financial Advisor

Has Received an Investment from Frog Hawley

Consumer

Jul 2024

$ 310,000,000

Advisor to Seller

Mergers & Acquisitions

Medtech, Healthcare

Jul 2024

£ 167,000,000

Sole Financial Advisor

Mergers & Acquisitions

Investment Funds & Real Estate

Jul 2024

€ 19,200,000

Sole Global Coordinator and Joint Bookrunner

Follow-on Offering

Healthcare

May 2024

$ 10,000,000

Sole Corporate Broker and Sole Bookrunner

Equity Placing

Healthcare

May 2024

Joint Corporate Broker

Energy & Natural Resources

Jan 2024

£ 218,700,000

Sole Financial Advisor

Mergers & Acquisitions

Investment Funds & Real Estate

Nov 2024

Advisor to Seller

Mergers & Acquisitions

Healthcare, Biopharma

Aug 2024

Advisor to Buyer

Has Executed a Majority Recapitalization with

Technology

Oct 2024

Advisor to Seller

Mergers & Acquisitions

Technology

Aug 2024

Joint Corporate Broker

Energy & Natural Resources

Mar 2024

Advisor to Seller

Mergers & Acquisitions

Technology

Jul 2024

Advisor to Seller

Mergers & Acquisitions

Consumer

Aug 2024

Advisor to Buyer

Mergers & Acquisitions

Healthcare

Nov 2024

Sole Financial Advisor

Mergers & Acquisitions

Healthcare Services

Oct 2024

Advisor to Seller

Mergers & Acquisitions

Healthcare

Jul 2024

Advisor to Seller

Mergers & Acquisitions

Consumer

Jul 2024

€ 52,500,000

Exclusive Debt Advisor

Secured Credit Facility

Healthcare

Jun 2024

£ 188,194,390

Advisor to Seller

Mergers & Acquisitions

Paper & Forest Products

May 2024

£ 8,700,000

Joint Bookrunner and Joint Corporate Broker

Equity Placing

Industrial Technology

Jun 2024

$ 11,500,000

Financial Advisor

Advisory

Healthcare

Jun 2024

Advisor to Seller

Mergers & Acquisitions

Paper & Forest Products

May 2024

€ 40,300,000

Joint Global Coordinator / Joint Bookrunner

Block Trade

Diversified Industries

May 2024

$ 538,000,000

Advisor to Buyer

Mergers & Acquisitions

Packaging

Mar 2024

$ 12,000,000

NOMAD, Sole Financial Advisor and Sole Bookrunner

Follow-on Offering

Healthcare

Mar 2024

£ 31,000,000

Joint Bookrunner, Joint Corporate Broker, NOMAD

Follow-on Offering

Healthcare

Mar 2024

$ 57,800,000

Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Feb 2024

Mergers & Acquisitions

Diversified Industries

Jan 2024

$ 75,300,000

Financial Advisor

Mergers & Acquisitions

Energy & Natural Resources

Dec 2023

$ 100,000,000

Financial Advisor

Convertible Loan Royalty

Energy & Natural Resources

Nov 2023

Financial Advisor

Mergers & Acquisitions

Consumer, Technology

Nov 2023

£ 100,000,000

Sole Financial Advisor Sole Placement Agent

Private Placement Joint Venture

Real Estate

Oct 2023

Advisor to Seller

Mergers & Acquisitions

Healthcare

Sep 2023

Advisor to Seller

Mergers & Acquisitions

Diversified Industries, Paper & Forest Products

Sep 2023

Financial Advisor

Private Debt

Software

Sep 2023

£ 10,000,000

Joint Bookrunner

Equity Placing

Healthcare

Jul 2023

$ 50,000,000

Sole Bookrunner

Follow-on Offering

Energy & Natural Resources

Jun 2023

£ 12,500,000

Nomad, Joint Broker and Joint Bookrunner

Equity Placing

Technology

May 2023

Advisor to Seller

Mergers & Acquisitions

Consumer

Apr 2023

£ 92,000,000

Joint Bookrunner

Follow-on Offering

Diversified Industries

Apr 2023

$ 163,000,000

Joint Global Coordinator and Joint Bookrunner

Follow-on Offering

Feb 2023

$ 20,300,000

Sole Placement Agent and Nomad

PIPE

Healthcare

Feb 2023

Advisor to Buyer

Mergers & Acquisitions

Technology

Jan 2023

$ 300,000,000

Advisor to Buyer

Mergers & Acquisitions

Packaging, Paper & Forest Products

Dec 2022

Advisor to Seller

Mergers & Acquisitions

Healthcare

Dec 2022

£ 10,482,996

Broker and Sole Bookrunner

Placing and Subscription

Internet & Digital Media

Oct 2022

£ 64,000,000

Sole Bookrunner, Sole Placement Agent, Sole Broker and Nomad

Convertible Bond & Follow-on Offering

Healthcare Services

Oct 2022

Advisor to Seller

Mergers & Acquisitions

Software

Sep 2022

Advisor to Buyer

Mergers & Acquisitions

Software

Sep 2022

€ 120,000,000

Advisor to Seller

Mergers & Acquisitions

Software

Oct 2022

$ 220,000,000

Joint Broker and Joint Bookrunner

Follow-on Offering

Technology

Sep 2022

Joint Global Coordinator and Joint Bookrunner

Follow-on Offering

Energy & Natural Resources

Sep 2022

Advisor to Seller

Mergers & Acquisitions

Software

Aug 2022

Advisor to Seller

Mergers & Acquisitions

Software

Sep 2022

$ 260,000,000

Advisor to Seller

Mergers & Acquisitions

Healthcare Services

Aug 2022

$ 480,000,000

Exclusive Financial Advisor

Tender Offer

Gaming & Leisure

Jun 2022

€ 30,000,000

Joint Global Coordinator and Euronext Growth Advisor

Initial Public Offering

Energy & Natural Resources

Jul 2022

£ 34,261,864

Joint Bookrunner

Follow-on Offering

Biopharma

May 2022

£ 300,000,000

Sole Sponsor, Financial Adviser, Global Coordinator, Bookrunner

Follow-on Offering

Real Estate

Apr 2022

$ 300,000,000

Advisor to Seller

Mergers & Acquisitions

Software

Dec 2020

$ 354,000,000

Joint Bookrunner

Follow-on Offering

Technology

Sep 2021

€ 15,000,000

Joint Global Coordinator and Joint Bookrunner

Follow-on Offering

Healthcare

Apr 2022

$ 30,000,000

Sole Financial Advisor and Sole Placement Agent

Convertible Bond and Equity Placing

Medtech

Mar 2022

£ 30,000,000

Financial Advisor, Sponsor & Nomad

Transfer of Listing to AIM

Consumer

Feb 2022

£ 130,000,000

Joint Bookrunner

Follow-on Offering

Diversified Industries

Jan 2022

Advisor to Buyer

Mergers & Acquisitions

Technology

Nov 2021

Advisor to Seller

Mergers & Acquisitions

Technology

Oct 2021

£ 50,000,000

Joint Bookrunner

Follow-on Offering

Diversified Industries

Oct 2021

£ 200,000,000

Sole Bookrunner and Financial Adviser

Follow-on Offering

Real Estate

Oct 2021

Advisor to Seller

Mergers & Acquisitions

Internet & Digital Media

Sep 2021

£ 125,000,000

Joint Bookrunner and Financial Adviser

Follow-on Offering

Real Estate

Sep 2021

$ 97,807,500

Joint Bookrunner

Initial Public Offering (U.S. Nasdaq)

Medtech

Jul 2021

Advisor to Buyer

Mergers & Acquisitions

Biopharma

Aug 2021

£ 17,000,000

Sole Global Coordinator, Joint Bookrunner & Nomad

Initial Public Offering

HealthTech

Jul 2021

Advisor to Seller

Mergers & Acquisitions

Software

Aug 2021

Advisor to Seller

Mergers & Acquisitions

Biopharma

Jul 2021

£ 300,000,000

Joint Bookrunner

Senior Sustainable Notes

Real Estate

Jun 2021

$ 128,600,000

Joint Global Coordinator and Joint Bookrunner

Initial Public Offfering

Internet & Digital Media

Jun 2021

$ 225,000,000

Joint Global Coordinator

Follow-on Offering

May 2021

£ 30,000,000

Advisor to Seller

Mergers & Acquisitions

Retail

Apr 2021

£ 150,000,000

Sole Bookrunner

Follow-on Offering

Real Estate

Mar 2021

£ 25,000,000

Sole Bookrunner

Follow-on Offering

Mar 2021

£ 104,400,000

Joint Bookrunner

Block Trade

Mar 2021

£ 60,000,000

Sole Bookrunner

Follow-on Offering

Real Estate

Mar 2021

$ 115,000,000

Joint Bookrunner

Follow-on Offering

Software

Oct 2020

£ 1,800,000,000

Financial Advisor

Mergers & Acquisitions

Sep 2020

£ 17,500,000

Sole Bookrunner

Follow-on Offering

Biopharma

Dec 2020

$ 56,600,000

Joint Bookrunner

Block Trade

Dec 2020

£ 89,200,000

Advisor to Seller

Mergers & Acquisitions

Software

Dec 2020

£ 110,500,000

Advisor to Seller

Mergers & Acquisitions

Software

Dec 2020

€ 200,000,000

Sole Bookrunner

Follow-on Offering

Real Estate

Oct 2020

€ 30,000,000

Joint Bookrunner

Follow-on Offering

Business Services

Nov 2020

Currency volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp. Unless otherwise indicated, information presented herein with respect to the experience of Stifel also includes transactions effected and matters conducted by companies acquired by Stifel.

Leadership Team

Rob Mann

Co-Head of Equities & Advisory Europe

London

Erickson Davis

Co-Head of Equities & Advisory Europe

London

Eline Lang

Director

Paris

Eric Madar

Paris

Guy Mullin Henderson

Managing Director

London

Ignacio Luzarraga

Managing Director, Stifel Europe Advisory GmbH, Spain

Madrid

James Ireland

Managing Director, Head of European Business Services

London

Jean De Pracomtal

Director

Paris

Jens Tschauder

Managing Director, Co-Head of European ECM

Frankfurt

Jerome Guyot

Managing Director

Paris

Jerome Raymond

London

Rachel Parry

Director

London

Rob Mann

Co-Head of Equities & Advisory Europe

London

Sebastian Schirl

Paris

Contact Stifel in Europe

Learn more about how we can help your business or organization.

Stifel Europe

Expanding Stifel Investment Banking Across European Borders

Our Services

Advisory

Capital Solutions

UK Corporate Broking

Equity Capital Markets

Private Capital Advisory

Financial Sponsors

Our Sector Expertise

Notable Transactions

Leadership Team

Rob Mann

Erickson Davis

Meet Our Team

Erik Anderson

Zishaan Arshad

C. Nicolas Bächstädt

Raphaël Bidaut

Matt Blawat

Alex Boyce

Ashish Burman

Ashton Clanfield

Kelly Curtin

Nicolas de Quincerot

Cyrus Deboo

Jean-Malo Dupart

Aamit Joshi

Samira Essebiyea

Jonathan Foiret Hurbin

Will Jungman

Alan Selby

Alex Price

Alexandre Ikeni

Amitabh Ghule

Anand Parekh

Andreas Kulcsar

Ben Maddison

Ben Tompkins

Berk Kirca

Bruno Benega

Callum Stewart

Celedonio Moncayo

Charles Hoare

Christoph Meseg

Christophe Alleman

David Laroque

Douglas Pinder

Dr. Bernd Schneider

Dr. Daniel Kiechle

Edward Gibson-Watt

Eline Lang

Eric Madar

Erickson Davis

Fabian Zimmer

Falk Müller Veerse

Florent Roulet

Florian du Fayet de la Tour

Francis North

Fred Walsh

Gareth Hunt

Guillaume Hannebelle

Guillaume Nathan

Guy Mullin Henderson

Ignacio Luzarraga

James Ireland

Jean De Pracomtal

Jens Tschauder

Jerome Guyot

Jerome Raymond

Jutta Wuebken

Klaus Nestler

Kristian Melandsø

Louis Jeng

Mark Whitfeld

Mark Young

Martin Eichler

Michael Wolff

Nicholas Moore

Olivier Beaudouin